These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22137732)

  • 21. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage.
    Lufft V; Kliem V; Hamkens A; Bleck JS; Eisenberger U; Petersen R; Ehlerding G; Maschek H; Pichlmayr R; Brunkhorst R
    Clin Transplant; 1998 Oct; 12(5):409-15. PubMed ID: 9787950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.
    Sabry A; Hassan R; Mahmoud I; Hamed M; Sobh M
    Iran J Kidney Dis; 2007 Oct; 1(2):88-97. PubMed ID: 19363283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation.
    Fernández-Fresnedo G; Plaza JJ; Sánchez-Plumed J; Sanz-Guajardo A; Palomar-Fontanet R; Arias M
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii47-51. PubMed ID: 15192136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction: proteinuria in renal transplant patients.
    Serón D
    Transplant Rev (Orlando); 2012 Jan; 26(1):1-2. PubMed ID: 22137725
    [No Abstract]   [Full Text] [Related]  

  • 27. Outpatient management of chronic kidney disease: proteinuria, anemia and bone disease as therapeutic targets.
    Lam A; Shah S; Paparello J
    Dis Mon; 2010 Apr; 56(4):215-32. PubMed ID: 20350654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High level of proteinuria during treatment with renin-angiotensin inhibitors is a strong predictor of renal outcome in nondiabetic kidney disease.
    Xie D; Hou FF; Fu BL; Zhang X; Liang M
    J Clin Pharmacol; 2011 Jul; 51(7):1025-34. PubMed ID: 20978279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms and risk factors for the development of the proteinuria after kidney transplantation.
    Melilli E; Cruzado JM; Bestard O; Hernández D
    Transplant Rev (Orlando); 2012 Jan; 26(1):14-9. PubMed ID: 22137727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical anatomical features of chronic dysfunction in the transplanted kidney].
    Tardanico R; Sandrini S
    G Ital Nefrol; 2004; 21 Suppl 26():S34-8. PubMed ID: 15732043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in renal function in renal transplantation. Predictive factors for functional deterioration].
    Jiménez del Cerro LA; Franco A; Rivera F; Olivares J
    Nefrologia; 2001; 21(3):295-304. PubMed ID: 11471310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mToR inhibitors-induced proteinuria: mechanisms, significance, and management.
    Letavernier E; Legendre C
    Transplant Rev (Orlando); 2008 Apr; 22(2):125-30. PubMed ID: 18631865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
    Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
    Artz MA; Hilbrands LB; Borm G; Assmann KJ; Wetzels JF
    Nephrol Dial Transplant; 2004 Nov; 19(11):2852-7. PubMed ID: 15466882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changing profiles of proteinuria in renal transplantation. Predictive factors for its appearance].
    Jiménez del Cerro LA; Franco A; Olivares J
    Nefrologia; 2002; 22(4):356-63. PubMed ID: 12369127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
    Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.